Advice provided by reference laboratory on final report where Taenia antibodies Gold 14 N/A HTD* applicable Advice provided by reference laboratory on final report where Tetanus antibodies Gold 14 N/A SJH* applicable Advice provided by reference laboratory on final report where Toxocara antibodies Gold 14 N/A HTD* applicable This assay has not been established with haemolysed, Toxoplasma antibodies Gold 5 4 wks In-house lipaemic or icteric, neonatal samples or cord blood. Advice provided by reference laboratory on final report where Toxoplasma confirmation Gold 10 N/A SHS* applicable Advice provided by reference laboratory on final report where Toxoplasma PCR Purple 7 N/A SHS* applicable Advice provided by reference laboratory on final report where Varicella zoster virus Purple 5 N/A LGI* applicable (VZV) PCR This assay has not been established with heat-activated, VZV IgG Gold 3 4 wks In house haemolysed, lipaemic or icteric samples. Advice provided by reference laboratory on final report where VZV IgM Gold 10 N/A LGI* applicable disease See Leptospira antibodies Weil’s
Taenia antibodies Gold 14 N/A HTD* Advice provided by reference laboratory on final report where applicable Tetanus antibodies Gold 14 N/A SJH* Advice provided by reference laboratory on final report where applicable Toxocara antibodies Gold 14 N/A HTD* Advice provided by reference laboratory on final report where applicable Toxoplasma antibodies Gold 5 4 wks In-house This assay has not been established with haemolysed, lipaemic or icteric, neonatal samples or cord blood. Toxoplasma confirmation Gold 10 N/A SHS* Advice provided by reference laboratory on final report where applicable Toxoplasma PCR Purple 7 N/A SHS* Advice provided by reference laboratory on final report where applicable Varicella zoster virus (VZV) PCR Purple 5 N/A LGI* Advice provided by reference laboratory on final report where applicable VZV IgG Gold 3 4 wks In house This assay has not been established with heat-activated, haemolysed, lipaemic or icteric samples. VZV IgM Gold 10 N/A LGI* Advice provided by reference laboratory on final report where applicable Weil’s disease See Leptospira antibodies
HDFT-USER-HANDBOOK-rev-009.docx